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Summary
Background Rapid demographic, epidemiological, and nutritional transitons have brought a pressing need to track 
progress in adolescent health. Here, we present country-level estimates of 12 headline indicators from the Lancet 
Commission on adolescent health and wellbeing, from 1990 to 2016.
Methods Indicators included those of health outcomes (disability-adjusted life-years [DALYs] due to communicable, 
maternal, and nutritional diseases; injuries; and non-communicable diseases); health risks (tobacco smoking, binge 
drinking, overweight, and anaemia); and social determinants of health (adolescent fertility; completion of secondary 
education; not in education, employment, or training [NEET]; child marriage; and demand for contraception satisﬁed 
with modern methods). We drew data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 
2016, International Labour Organisation, household surveys, and the Barro-Lee education dataset.
Findings From 1990 to 2016, remarkable shifts in adolescent health occurred. A decrease in disease burden in many 
countries has been oﬀset by population growth in countries with the poorest adolescent health proﬁles. Compared 
with 1990, an additional 250 million adolescents were living in multi-burden countries in 2016, where they face a 
heavy and complex burden of disease. The rapidity of nutritional transition is evident from the 324·1 million (18%) of 
1·8 billion adolescents globally who were overweight or obese in 2016, an increase of 176·9 million compared with 
1990, and the 430·7 million (24%) who had anaemia in 2016, an increase of 74·2 million compared with 1990. Child 
marriage remains common, with an estimated 66 million women aged 20–24 years married before age 18 years. 
Although gender-parity in secondary school completion exists globally, prevalence of NEET remains high for young 
women in multi-burden countries, suggesting few opportunities to enter the workforce in these settings.
Interpretation Although disease burden has fallen in many settings, demographic shifts have heightened global 
inequalities. Global disease burden has changed little since 1990 and the prevalence of many adolescent health risks 
have increased. Health, education, and legal systems have not kept pace with shifting adolescent needs and 
demographic changes. Gender inequity remains a powerful driver of poor adolescent health in many countries.
Funding Australian National Health and Medical Research Council, and the Bill & Melinda Gates Foundation.
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Introduction
Adolescence is a formative phase of life during which 
patterns of growth, development, and behaviour lay a 
foundation for health in later life and for the next 
generation.1,2 The importance of adolescent health has 
been further heightened by the population of people 
aged 10–24 years  being the largest in history, at 
1·8 billion in 2016.3 In response, in 2015 the United 
Nations (UN) extended the existing Every Woman, Every 
Child agenda to include adolescents through the Global 
Strategy for Women’s, Children’s, and Adolescents’ 
Health.4–6
The Global Strategy highlighted a need for sound 
health data to drive accountability.1,7 Adolescents were 
mentioned in 12 of 232 Sustainable Development Goals 
(SDGs) indicators relevant to health, including indicators 
associated with nutrition, reproductive health, sexual 
and intimate partner violence, child marriage, education, 
and employment.8 The 60 indi cators for the Global 
Strategy overlapped with those of the 12 SDGs and 
included adolescent mortality and fertility as adolescent-
speciﬁc indicators.9,10 The inclusion of adolescents in 
Countdown to 2030,11 in which focus had previously 
been exclusively on maternal and child health, marked 
a further step towards a system for tracking adolescent 
health. However, in these and other initiatives designed 
to monitor progress in adolescent health and wellbeing 
(eg, the United Nations [UN] International Children’s 
Emergency Fund’s [UNICEF] proposed National 
Adolescent Assessment Cards12), the lack of good 
quality and timely data has remained a barrier to 
progress.13 Failure to include all adolescents in routine 
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data collections has led to gaps, particularly for younger 
adolescents (aged 10–14 years), males, and those out of 
school.1,14 Additionally, many aspects of adolescent 
health and health risk, including mental and substance 
use disorders and sexual violence and abuse remain 
poorly covered in existing global surveys.7,15,16
The 2016 Lancet Commission on adolescent health 
and wellbeing1 proposed a set of 12 headline indicators 
as an interim mechanism for tracking progress in 
adolescent health. The indicators were deﬁned for their 
comparatively high data coverage and quality. They 
captured disease burden, health risks, and prominent 
social determinants of health during the adolescent 
years.1,17 We aimed to populate these indicators with data 
for 195 countries and territories from 1990 to 2016. We 
additionally aimed to aggregate these estimates for each 
country and group the countries into three disease-
burden groups that were laid out by the Commission, 
and to delineate shifting priorities with progression 
through the epi demiological transition.1
Methods
Data sources and definitions 
We populated the 12 headline indicators for adolescent 
health as deﬁned by the Lancet Commission on 
adolescent health and wellbeing (table 1),1 hereafter 
referred to as the Commission, with global, country-level, 
and disease-group data. In selecting data sources, we 
considered coverage, data quality, international com-
parability, and recency of data. We ﬁrst reviewed relevant 
data available at the Institute of Health Metrics and 
Evaluation (IHME). Although some data might be 
available elsewhere, IHME has extensively catalogued 
primary health data for each country across the world. 
For their Global Burden of Diseases, Injuries, and Risk 
Factors Study (GBD), they have harmonised estimates 
and used models to ﬁll data gaps to produce estimates 
that are updated annually for 333 health outcomes 
and 84 risks and determinants by country or territory, 
sex, and 5-year age group.18,19 We used data from GBD 
2016, which included 195 countries and territories. 
Research in context
Evidence before this study
A lack of well defined indicators that can be readily populated 
with data has been a barrier to progress and investment in 
adolescent health and wellbeing. We reviewed existing 
indicator frameworks as part of the 2016 Lancet Commission 
on adolescent health and wellbeing, and then as part of a 
technical working paper for United Nations (UN) International 
Children’s Emergency Fund’s (UNICEF) in 2017.  We reviewed 
the Sustainable Development Goals; the Global Strategy of 
Women’s Children’s and Adolescent’s Health; UNICEF’s 
proposed adolescent health tracker; Countdown to 2030; 
a mapping of adolescent health indicators in a Lancet series on 
adolescent health; and earlier work by WHO to define core 
indicators of adolescent health. Indicator frameworks 
published before the Commission have had little comparability, 
captured restricted aspects of adolescent health, and generally 
mapped poorly to available data. The Commission proposed 
12 headline indicators that mapped to a conceptual model for 
adolescent health and wellbeing that encompassed major 
health needs, health risks, and social determinants of health. 
The headline indicators were designed to capture shifting 
patterns of adolescent health with progress through the 
epidemiological transition and availability through existing 
data sources.
Added value of this study
To our knowledge, this is the first comprehensive and integrated 
overview of recent global shifts in adolescent health at a global 
level, extending to country-level estimates for 195 countries 
and territories. We outline the shifts in adolescent health needs 
that have taken place between 1990 and 2016 in the context of 
rapid epidemiological and nutritional transitions and major 
demographic changes. We describe trends in health risks and 
major social determinants of health. We also report trends over 
time for each indicator since 1990 to identify in which countries 
the least progress has been made and where health needs are 
rapidly emerging.
Implications of all the available evidence
A pressing need exists for adoption of comprehensive and 
integrated approaches to adolescent health and monitoring 
the success of these investments. Disease burden has 
decreased in many countries, but demographic shifts mean 
many more adolescents face major health problems. 
Geographical inequality has increased with a shift in disease 
burden to countries that have the lowest resources and the 
largest adolescent populations. Compared with 1990, 
an additional 250 million adolescents lived in multi-burden 
countries in 2016, where they faced a triple burden of health 
problems extending from infectious diseases and other 
group 1 causes of disease burden, to high prevalences of 
injury, violence, and non-communicable diseases including 
mental disorders. Nutritional health risks have become more 
prominent with a 120% increase in the prevalence of 
adolescent overweight or obesity. Furthermore, the absolute 
number of adolescents living with anaemia was 20% higher in 
2016 than in 1990. Indicators reflecting the capacity of health, 
educational, employment, and legal systems suggest that they 
have not kept pace with rapid demographic and geographical 
shifts in adolescent needs. To ensure targeted and accountable 
action, the global community must now agree on a minimum 
set of well defined indicators that are specific to adolescent 
health and that can be readily populated with data; the 
indicators as reported here could provide an important 
foundation for this task.
For the Institute of Health 
Metrics and Evaluation, Global 
Health Data Exchange see 
http://ghdx.healthdata.org/
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Speciﬁc methods and deﬁnitions of GBD 2016 are 
described elsewhere.18–21 Data for some indicators of 
social determinants were not readily available at IHME 
and we reviewed other relevant global data collections to 
obtain these.7,13
In the Commission, the indicators were organised into 
three main categories: health outcomes, health risks, and 
social determinants of health. Brief deﬁnitions of each 
indicator and the data sources used are shown in table 1 
(full deﬁnitions of each indicator and data sources are in 
the appendix). Indicators were generally deﬁned for 
adolescents aged 10–24 years. This age deﬁnition reliably 
captures developmental stage during biological, social, 
and neurocognitive transitions.3
We reported indicators for adolescents in 195 locations, 
as deﬁned by IHME, comprising 188 countries (as 
classiﬁed by the UN) and seven territories (Puerto Rico, 
American Samoa, Bermuda, Greenland, Guam, Northern 
Mariana Islands, and the Virgin Islands). Hereafter, 
countries refers to both UN countries and territories. 
Because the population of these 195 countries is more 
than 99·9% of the global population, in this analyses we 
report our data as global estimates.
The Commission deﬁned three country disease groups 
(country groups) on the basis of adolescent disease burden 
to represent diﬀerent stages of the epidemiological trans-
ition (and therefore diﬀerent patterns of health need) for 
adolescents.1 
Countries were deﬁned as multi-burden if adolescents 
(aged 10–24 years, both sexes combined) of that country 
had a burden of communicable, maternal, and nutritional 
con ditions (ie, group 1 conditions; table 1) of 2500 disability-
adjusted life-years (DALYs) or more per 100 000 adolescents. 
This threshold was set using GBD 2013 data to capture 
countries where DALYs caused by group 1 conditions in 
2013 were at least double the average rate for countries 
where non-communicable diseases were predominant, 
and countries where group 1 conditions accounted for at 
least 20% of the total burden among those aged 10–24 years. 
Countries were deﬁned as injury excess if adolescents 
were estimated to have 2500 DALYs or more per 
100 000 adolescents due to injury and less than 2500 DALYs 
Data source Countries 
covered 
(n=195)
Definition Short title
Health outcome
DALYs due to communicable, maternal, and 
nutritional diseases in individuals aged 
10–24 years
IHME 195 (100%) DALYs per 100 000 adolescents due to communicable, maternal, and 
nutritional diseases in individuals aged 10–24 years
Group 1 DALYs
DALYs due to injury and violence in 
individuals aged 10–24 years
IHME 195 (100%) DALYs per 100 000 adolescents due to injury and violence in individuals 
aged 10–24 years
Injury DALYs
DALYs due to non-communicable diseases in 
individuals aged 10–24 years
IHME 195 (100%) DALYs per 100 000 adolescents due to non-communicable diseases in 
individuals aged 10–24 years
Non-communicable 
disease DALYs
Health risks
Daily smoking in individuals aged 10–24 years IHME 195 (100%) Prevalence of use of any smoked tobacco product in individuals aged 
10–24 years
Daily tobacco
Binge drinking in past 12 months in 
individuals aged 15–19 years
IHME 195 (100%) Prevalence of binge alcohol use (>48 g of alcohol for females, >60 g for 
males) in the past 12 months for individuals aged 15–19 years
Binge drinking
Individuals aged 10–24 years who exceed 
WHO guidelines for overweight
IHME 195 (100%) Prevalence of overweight and obesity (IOTF thresholds, age-specific and 
sex-specific thresholds, equivalent to a BMI ≥25 kg/m² at age 18 years) in 
individuals aged 10–24 years
Overweight and 
obesity
Prevalence of iron deficiency anaemia in 
individuals aged 10–24 years
IHME 195 (100%) Prevalence of anaemia in individuals aged 10–24 years: for those aged 
10–14 years haemoglobin <115 g/L; for those aged 15–24 years, <130 g/L for 
males, <120 g/L for non-pregnant females, and <110 g/L for pregnant 
females
Anaemia
Social determinants of health
Completing ≥12 years of education among 
individuals aged 20–24 years
Barro-Lee 143 (93%) Proportion completing secondary school among individuals aged 
20–24 years
Secondary education
Individuals aged 20–24 years who are NEET International Labour 
Organization
123 (75%) Proportion of individuals aged 15–24 years not in employment, education, 
or training
NEET
Annual birth rate per 1000 adolescents aged 
10–19 years
IHME 195 (100%) Birth rate (livebirths per 1000 population per year) in females aged 
15–19 years
Adolescent livebirths
Marriage before age 18 years in women aged 
20–24 years
Multiple Indicator Cluster 
Survey and Demographic 
and Health Survey
120 (62%) Proportion of females aged 20–24 years in marriage or union before age 
18 years
Child marriage
Females aged 15–24 years with met need for 
contraception
IHME 195 (100%) Proportion of females aged 15–24 years whose demand for contraception is 
satisfied with a modern method
Demand for modern 
contraception satisfied
DALYs=disability-adjusted life-years. IHME=Institute for Health Metrics and Evaluation. IOTF=World Obesity Federation. BMI=body-mass index. NEET=not in education, employment, or training.
Table 1: Definitions and data availability for 12 headline indicators of adolescent health from the Lancet Commission on adolescent health and wellbeing
See Online for appendix
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per 100 000 population due to group 1 conditions. This 
threshold was set to identify those countries that had a low 
burden of group 1 conditions but that had a burden of 
injuries at least twice that of countries where non-
communicable diseases were predominant, and countries 
where injury accounted for least 20% of the total burden 
for adolescents. 
Countries were deﬁned as non-communicable 
disease predominant if both injuries and group 1 con-
ditions each contributed less than 2500 DALYs per 
100 000 adolescents to the disease burden. We used these 
deﬁnitions to deﬁne country groups in 1990 and 2016; 
country groupings reported are for 2016 unless otherwise 
speciﬁed. Hence, with progression through the epi-
demiological transition, a country would be expected to 
move up from the multi-burden group to the injury 
excess group, and from the injury-excess group to the 
non-communicable disease-predominant group. These 
country groupings broadly corresponded to socio-
economic development (deﬁned in the appendix). The 
median Socio-demographic Index (SDI) value for 
multi-burden countries was 0·45 (range 0·19–0·74), 
which was generally lower than injury-excess countries 
(SDI median 0·71, range 0·47–0·88) and the non-
communicable disease-predominant countries (SDI 
median 0·8, range 0·45–0·94). The country groupings 
also broadly corresponded with World Bank income 
levels, with almost all (30 [97%] of 31) low-income 
countries in 2016 classiﬁed as multi-burden and almost 
all (52 [88%] of 59) high-income countries classiﬁed as 
non-communicable disease predominant (appendix).
Analysis and reporting
We report the most recent estimate for each indicator at 
a country level. For each indicator we identiﬁed the 
countries with the lowest and highest observed values 
and ranked each country in between, presenting this 
ranking as a heat map. We also report estimates for 
each indicator for the three country groups and globally. 
We report group estimates using country-level 
estimates for 2016 for indicators drawn from IHME, 
2010 estimates for secondary education, and the most 
recent country-speciﬁc data available for child marriage 
(2003–16), and not in education, employment, or 
training (NEET; 2005–16; appendix). For indicators 
drawn from IHME data, we generated group counts 
as the sum of counts in each country. We then used 
these group counts of numerator and denominator 
to generate estimates of group prevalence. For the 
indicators of secondary education, child marriage, and 
NEET, the group prevalence estimates reﬂect only 
countries for which data were available, and we 
calculated the count estimates (estimated number of 
adolescents) using the prevalence derived from the 
available data and applied that to the total denominator 
population of that group. For the indicator of child 
marriage, data were not available for many countries 
in the non-communicable disease-predominant group 
and data were mostly missing for high-income 
countries. To estimate the count and prevalence of 
child marriage in the non-com municable disease-
predominant country group, we assumed that non-
communicable disease-predominant countries without 
an estimate had a prevalence equivalent to the lowest 
prevalence observed in the rest of the group. Data for 
child marriage were of suﬃcient coverage for injury-
excess and multi-burden countries. In addition to 
estimating the group counts on the basis of observed 
data, we estimated global counts from two scenarios 
to distinguish changes between 1990 and 2016 due 
to shifts in health and due to population change—ie, 
stable demography and changing epidemiology, and 
changing demography with ﬁxed epidemiology.
We populated indicators associated with NEET and 
child marriage from primary data; however, standard 
errors (and therefore conﬁdence intervals) were not 
readily available for these estimates. We drew data for 
estimates for the other indicators from modelled data 
based on multiple individual primary data sources. 
Uncertainty estimates for these estimates (distinct from 
conﬁdence intervals in that they represent uncertainty 
derived from primary data, model estimation, and model 
speciﬁcation) were available at a country level for 
adolescents but were not readily available for mani pulated 
data (including aggregate country groupings). Uncertainty 
estimates at a country level for indicators drawn from 
IHME (other than adolescent fertility) are provided in the 
appendix. Adolescent fertility in GBD 2016 was modelled 
using a hybrid approach of modelling the total fertility 
rate directly and then ﬁtting UN World Population 
Prospects age patterns of fertility to those estimates; un-
certainty estimates for adolescent fertility were not 
available. Uncertainty estimates were not available for 
indicators of injury and non-communicable disease 
burden because of the redistribution of self-harm from the 
IHME level 1 injury group to the level 1 non-communicable 
disease group because of its association with mental 
disorders. To enable assessment of data quality, we 
provide uncertainty estimates for the IHME level 1 groups 
and self-harm separately. Furthermore, we provide 
uncertainty estimates for all-cause years of life lost (YLL) 
and years lost due to disability (YLD) for adolescents to 
allow an assessment of the quality of data of the two broad 
components of DALYs.
We report annual rates of change for each indicator at a 
country and group level. Linear regression models were 
ﬁtted to available data points for each indicator and location, 
and we used the β coeﬃcient to estimate the annual rate of 
change (expressed as percentage change). We used linear 
regression (rather than the estimates at each extreme of the 
time series) to account for ﬂuctuations in some indicators 
over time (eg, an increase in DALYs due to war or conﬂict). 
We used data points for 1990–2015 in intervals of 5 years 
plus 2016 for data drawn from IHME. For data drawn 
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from Barro-Lee, an educational attainment dataset that 
covers the period 1950–2010, we used intervals of 5 years 
for data from the period 1990–2010. Rates of change for 
NEET and child marriage could not be caulated because of 
restricted data over time.
Role of the funding source
The funders provided salaries for research staﬀ and had 
no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. PSA, SJCH, KLF, 
ECK, and GCP had access to all the data; AHM, NJK, SL, 
A 1990
B 2016
C Population share by group
Multi-burden
Injury excess
Non-communicable disease
 predominant
1990
2016
Ye
ar
100200300400500600700800900
Female population (millions)
0 100 200 300 400 500 600 700 800 900
Male population (millions)
466·8
349·0
117·0
355·4
287·6
46·4
496·0
364·1
122·3
370·5
311·6
48·4
Figure 1: Adolescent health country groupings in 1990 (A) and 2016 (B) with population distribution of adolescents in the three groups at both timepoints, 
by sex (C)
For Barro-Lee website see 
http://www.barrolee.com/
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CMSI, and TV had access to all the data as provided 
by IHME; and all other authors able to access the data 
as requested. The corresponding author had ﬁnal respon-
sibility for the decision to submit for publication.
Results
Global trends in adolescent health and demography
In 1990, 90 (46%) of 195 countries were classiﬁed as 
multi-burden, which included most countries in sub-
Saharan Africa; central, south, and east Asia; and several 
countries in Latin America, Oceania, the Middle East, 
and north Africa (ﬁgure 1). 73 (38%) countries were 
classiﬁed as injury excess in 1990, mostly in eastern 
Europe and Latin America, but also several countries in 
western Europe (including France, Spain, Switzerland), 
the Middle East, and the USA. The remaining 
32 (16%) countries were classiﬁed as non-communicable 
disease predominant.
Between 1990 and 2016, 73 (37%) countries shifted 
their disease group, all of which progressed through the 
epidemiological transition, except for Dominica, Jamaica, 
Paraguay, and Syria, which moved from the non-
communicable disease-predominant group to the injury-
excess group (ﬁgure 1). No country moved back to 
multi-burden. By 2016, many countries in central and 
east Asia, western Europe, the Middle East, and the 
Americas had made a transition to the non-communicable 
disease-predominant group, with 88 (45%) countries in 
this group. Of the countries in this group, most 
transitioned from being in the injury-excess group in 
1990 (49 [56%]), but 11 (13%) made the transition from 
multi-burden to non-communicable disease predominant 
(Bolivia, Egypt, Kyrgyzstan, the Maldives, Morocco, 
Peru, Samoa, Sri Lanka, Tajikistan, Turkmenistan, and 
Uzbekistan). In 2016, the multi-burden group comprised 
70 (36%) countries, which were predominantly in sub-
Saharan Africa and south Asia. The 37 (19%) countries in 
the injury-excess group in 2016 (including nine countries 
that had transitioned from the multi-burden group) were 
predominantly in eastern Europe, central Asia, and Latin 
America.
Population-level changes are shown in ﬁgure 1C. In 1990, 
the global population of individuals aged 10–24 years was 
estimated to be 1·53 billion people (783·0 million males 
and 750·8 million females), with 713·1 million (46%) living 
in multi-burden countries, 725·9 million (47%) in injury-
excess countries, and 94·8 million (6%) in non-
communicable disease-predominant countries. In 2016, 
the adolescent population had increased to 1·8 billion 
people (929·9 million males and 871·4 million females). 
Health outcomes Health risks Social determinants of health
Group 1 
DALYs
Injury 
DALYs
Non-
communicable 
disease DALYs
Total 
DALYs
Daily 
tobacco
Binge 
drinking*
Overweight 
and obesity
Anaemia Secondary 
education†
NEET‡ Adolescent 
livebirths* 
(per 1000 
population)
Child 
marriage†
Demand for 
modern 
contraception 
satisfied‡
Multi-burden
Female 6334·5 
(–1·6%)
1477·7 
(–1·1%)
8259·2 
(–0·6%)
16 071·4 
(–1·1%)
1·5% 
(+1·2%)
4·3% 
(+0·7%)
13·0% 
(+5·7%)
40·2% 
(–0·4%)
42·1% 
(+14·9%)
40·3% 
(NA)
54·2 
(–1·7%)
38·2% 
(NA)
53·0% 
(+2·1%)
Male 5141·5 
(–1·3%)
3723·5 
(–0·5%)
8121·8 
(–0·3%)
16 986·8 
(–0·7%)
9·2% 
(–0·4%)
7·2% 
(+0·4%)
11·1% 
(+4·8%)
29·3% 
(–0·4%)
43·0% 
(+9·5%)
8·3% 
(NA)
·· ·· ··
Injury excess
Female 1372·0 
(–1·4%)
1780·6 
(–0·8%)
7837·4 
(–0·2%)
10 990·0 
(–0·5%)
2·8% 
(–2·1%)
13·5% 
(+0·2%)
28·1% 
(+3·3%)
14·3% 
(–0·7%)
62·1% 
(+3·7%)
26·7% 
(NA)
52·6 
(–1·0%)
24·0% 
(NA)
72·7% 
(+1·0%)
Male 1226·9 
(–1·4%)
7242·7 
(–0·3%)
8054·3 
(–0·1%)
16 523·9 
(–0·4%)
11·3% 
(–1·5%)
20·3% 
(+0·1%)
25·6% 
(+3·8%)
11·1% 
(–0·8%)
56·0% 
(+3·0%)
12·7% 
(NA)
·· ·· ··
Non-communicable disease predominant
Female 917·6 
(–1·8%)
961·5 
(–1·9%)
7567·2 
(–0·6%)
9446·4 
(–1·0%)
5·1% 
(–1·2%)
17·0% 
(+0·3%)
22·7% 
(+3·9%)
13·6% 
(–0·3%)
61·1% 
(+0·3%)
18·4%§ 
(NA)
14·1 
(–1·8%)
3·58%¶ 
(NA)
78·1% 
(+0·6%)
Male 798·9 
(–1·6%)
2766·9 
(–1·7%)
7201·9 
(–0·6%)
10 767·7 
(–1·0%)
16·8% 
(–1·0%)
24·0% 
(+0·4%)
25·3% 
(+3·5%)
9·1% 
(–0·3%)
60·5% 
(+0·2%)
12·6%§ 
(NA)
·· ·· ··
Global
Female 3880·2 
(–1·1%)
1348·0 
(–1·2%)
7974·1 
(–0·5%)
13 202·4 
(–0·8%)
2·8% 
(–1·5%)
9·6% 
(–0·3%)
18·2% 
(+3·6%)
27·9% 
(+0·1%)
53·3% 
(+1·9%)
32·8%§ 
(NA)
41·2 
(–1·3%)
22·8%¶ 
(NA)
66·6% 
(+0·7%)
Male 3171·5 
(–0·9%)
3865·8 
(–0·9%)
7804·7 
(–0·4%)
14 841·8 
(–0·6%)
12·0% 
(–1·2%)
14·4% 
(–0·3%)
17·8% 
(+3·1%)
20·1% 
(+0·1%)
52·6% 
(+1·5%)
10·0%§ 
(NA)
·· ·· ··
Data are DALYs per 100 000 adolescents for health outcomes and prevalence for health risks and determinants with the exception of livebirths, which are per 1000 population, with the annual rate of change in 
parentheses where available. Estimates are the most recent available (2010 for education [except New Zealand, 2005], median of 2013 for child marriage, median of 2015 for NEET, and 2016 for all others) for 
adolescents aged 10–24 years, unless otherwise stated. Data were available for over 80% of the denominator population, unless otherwise indicated. DALYs=disability-adjusted life-years. NA=not applicable. 
NEET=not in education, employment, or training. *For individuals aged 15–19 years. †For individual aged 20–24 years. ‡For individuals aged 15–24 years. §Coverage was only 50–80% of the denominator 
population of this country group. ¶These estimates for child marriage are based on low coverage primary data (18%; see methods for detail on estimation).
Table 2: Contemporary estimates for indicators of adolescent health across the three country groups and rates of change since 1990
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This population growth largely occurred in countries that 
were classiﬁed as multi-burden in 2016 (appendix). As a 
result, the global population share of adolescents living in 
multi-burden countries increased from 46% in 1990 to 
53% (962·8 million) in 2016, an increase of 249·6 million 
adolescents. In 2016, 239·3 million (13%) adolescents 
lived in countries classiﬁed as injury excess, a decrease of 
486·5 million adolescents since 1990. By 2016, the 
proportion of adolescents living in countries that were 
non-communicable disease predominant had increased 
to 599·3 million (33%), an increase of 504·4 million 
people. Population change by World Bank income group 
are shown in the appendix; 945 million (60%) adolescents 
in 1990 lived in low-income countries, whereas in 2016 
most adolescents lived in lower-middle-income countries 
(835 million [46%]) and upper-middle-income countries 
(544 million [30%]). India and China together accounted 
for a third (622 million [35%]) of the global population of 
adolescents in 2016. India’s adolescent population 
increased by 40%, from 264 million in 1990 to 370 million 
in 2016; however, China’s adolescent population de-
creased by 28% from 352 million in 1990 to 253 million in 
2016 (appendix).
Indicator estimates for country groupings and 
individual countries
Estimates for each indicator globally and across the three 
country groupings (including annual rates of change) are 
shown in table 2. Estimates of the global counts of 
adolescents for each indicator are shown in ﬁgure 2; 
counts across the three country groupings are in the 
appendix. Indicator estimates for individual countries are 
shown in ﬁgure 3, with the distribution of estimates and 
country-level rates of change shown in the appendix. 
Here we provide a summary of key ﬁndings by indicator, 
presenting trends at a global and country-group level, and 
then some key ﬁndings at a country level.
Health outcomes
Adolescents had a total burden of 253 million DALYs in 
2016 (ﬁgure 2); 159 million DALYs (63%) were among 
adolescents in multi-burden countries; 33 million 
(13%) in injury-excess countries; and 61 million (24%) 
in non-communicable disease-predominant countries 
(appendix). A global de crease of 11 million DALYs 
occurred between 1990 and 2016, largely driven by 
epidemiological change (appendix). The prevalence of 
DALYs was highest in the multi-burden group and 
lowest in the non-communicable disease-predominant 
group for both males and females (table 2). Males in the 
injury-excess group had a DALY prevalence similar to 
1990 2010 2015 1990 2016 2013 1990 2016
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livebirths*§
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education†
Child 
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Group 1 DALYs Injury DALYs Non-communicable
diesease DALYs
Total DALYs
Daily tobacco Binge drinking* Overweight and 
obesity
Anaemia
159·7
91·1
174·7
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146·0
85·1
165·3
97·4
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11·715·4
69·569·0
115·1
125·3
29·531·8 35·940·1
72·666·9
138·0138·8
24·8
34·4 27·326·1
158·9
70·5
243·4
202·6
111·5
139·8
43·941·4
165·2
76·7
187·3
153·9
Female
Male
Health outcomes
Health risks
Social determinants of health
Figure 2: Global counts for 12 indicators of adolescent health in 1990 and 
2016, by sex
Data are DALY counts in millions, or population in millions. Each indicator is 
shown at two timepoints, except for NEET and child marriage because 
insufficient data were available. Counts for NEET, child marriage, and secondary 
education are estimated using group-specific prevalences (on the basis of 
available data) and applied to total denominator counts. Data are for adolescents 
aged 10–24 years, unless otherwise stated. DALYs=disability-adjusted life-years. 
NEET=not in education, employment, or training. *For individuals aged 
15–19 years. †For individual aged 20–24 years. ‡For individuals aged 15–24 years. 
§Counts for livebirths are incident births, and do not include girls aged 
15–19 years who gave birth before 2016.
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Multi-burden countries
Afghanistan
Angola
Bangladesh
Benin
Bhutan
Botswana
Burkina Faso
Burundi
Cambodia
Cameroon
Cape Verde
Central African Republic
Chad
Comoros
Congo (Brazzaville)
Côte d’Ivoire
DR Congo
Djibouti
Equatorial Guinea
Eritrea
Ethiopia
Federated States of Micronesia
Fiji
Gabon
Ghana
Guinea
Guinea-Bissau
Guyana
Haiti
India
Indonesia
Kenya
Kiribati
Laos
Lesotho
Liberia
Madagascar
Malawi
Mali
Marshall Islands
Mauritania
Mozambique
Myanmar
Namibia
Nepal
Niger
Nigeria
Pakistan
Papua New Guinea
Philippines
Rwanda
São Tomé and Príncipe
Senegal
Sierra Leone
Solomon Islands
Somalia
South Africa
South Sudan
Sudan
Swaziland
Tanzania 8·3
12·8
2·8
10·8
9·1
9·6
2·9
8·7
6·0
3·7
6·1
2·8
4·7
3·3
7·7
8·0
2·9
6·4
3·7
13·6
4·2
2·5
7·9
13·3
6·8
8·5
18·7
2·8
3·9
8·8
2·9
3·9
4·4
2·4
10·1
8·1
6·7
6·2
2·5
2·3
6·5
7·0
8·8
6·3
9·5
9·3
8·5
5·1
9·3
17·6
2·9
9·0
4·3
9·6
8·4
5·8
3·0
6·9
2·3
6·4
3·2
9·1
14·5
4·1
12·2
11·9
10·7
3·8
9·7
6·1
3·5
6·0
2·6
6·0
5·1
7·5
9·3
3·7
7·0
2·9
14·4
5·2
2·8
9·6
13·2
7·5
9·1
21·4
3·5
4·5
8·3
3·2
5·9
5·7
2·9
10·0
9·6
6·9
6·5
2·6
2·8
6·6
7·4
9·3
6·5
10·0
9·8
10·1
5·2
11·4
16·8
2·9
10·3
3·7
9·4
9·1
6·7
4·2
7·1
3·0
6·9
6·1
3·5
7·4
6·2
4·0
6·9
7·2
4·5
2·9
2·9
2·8
3·2
3·5
5·4
3·9
2·1
2·8
3·1
6·3
4·0
4·1
2·0
4·2
2·7
2·9
2·8
2·4
10·0
4·5
3·1
2·6
3·1
3·2
7·3
6·1
4·4
3·1
2·6
3·9
3·9
4·1
3·5
3·7
3·0
3·3
4·2
3·8
3·7
3·0
3·4
7·8
4·5
3·6
5·4
3·8
2·8
4·7
2·5
3·0
3·4
4·1
17·4
1·3
1·8
1·9
1·7
3·2
3·0
1·8
1·2
1·0
0·7
1·4
1·0
2·0
1·6
0·8
1·1
1·1
1·3
1·2
1·2
0·9
1·5
1·2
1·1
1·2
1·0
2·1
1·6
1·3
0·9
0·9
1·6
2·8
1·7
1·5
1·2
1·1
1·5
1·7
1·6
1·4
1·4
1·2
1·1
1·5
1·4
1·7
1·4
1·2
2·3
0·8
1·3
1·4
1·5
1·3
1·3
1·0
1·1
1·0
1·6
5·3
8·2
9·5
8·6
7·9
8·5
8·8
11·0
9·1
8·7
8·4
8·0
8·6
11·1
8·8
7·7
8·1
8·0
8·4
8·5
8·2
7·8
11·0
7·8
9·4
9·7
8·0
10·1
9·7
15·2
7·3
7·6
7·7
9·4
10·3
10·3
9·0
8·6
7·8
10·7
10·8
8·6
8·7
7·0
8·6
8·2
9·8
7·6
8·2
8·8
9·6
9·3
9·4
8·5
8·7
9·2
8·5
7·9
9·3
8·1
7·8
9·1
7·1
7·7
9·4
7·2
9·0
7·8
10·3
9·4
7·4
7·8
7·1
8·1
10·0
9·0
7·7
7·9
7·9
6·9
6·9
7·1
7·6
9·5
7·8
7·9
8·0
7·9
8·5
8·5
9·8
6·4
6·9
8·8
10·4
10·2
8·2
8·8
7·4
7·3
9·5
9·5
7·1
7·2
7·0
7·0
7·6
8·4
7·4
7·5
8·0
8·2
7·2
8·4
7·3
7·5
9·6
7·2
7·5
8·8
8·2
7·5
11·2
20·0
29·7
17·5
22·7
24·5
25·7
18·4
20·7
17·6
14·9
17·3
14·8
21·2
16·0
17·5
19·0
14·1
21·1
16·2
25·9
13·9
17·7
18·3
25·6
19·3
19·0
38·8
17·0
22·2
18·7
13·7
14·8
21·1
18·9
24·7
20·1
17·9
17·8
17·1
17·2
18·7
19·4
18·8
18·3
21·9
22·9
19·7
16·3
21·6
34·9
16·6
22·0
18·1
22·1
20·4
19·0
13·4
19·2
13·8
18·3
29·7
17·4
24·0
15·4
21·0
24·1
21·5
15·8
20·3
14·5
12·0
14·5
11·7
18·0
15·7
16·0
18·3
12·7
15·2
11·0
22·7
13·7
13·8
18·6
22·2
16·7
18·1
32·0
13·5
15·6
15·7
11·0
16·3
18·9
14·8
19·8
19·6
15·3
15·2
13·7
13·8
15·1
15·9
17·5
14·5
19·1
19·5
19·2
14·1
20·6
27·3
10·9
20·0
12·4
18·4
20·0
15·2
12·6
17·0
12·1
16·0
22·6
6·5
4·4
4·9
5·0
12·5
5·4
18·8
8·0
4·5
1·8
3·9
19·5
26·3
7·8
2·2
4·5
8·3
9·3
9·5
6·3
11·5
16·7
5·6
5·5
10·0
2·5
17·9
23·9
24·3
4·4
28·6
7·6
3·4
7·2
5·3
7·6
1·4
9·1
10·7
19·3
2·0
3·6
2·0
9·9
6·3
7·7
5·0
7·7
3·8
5·9
3·8
3·4
10·4
5·3
5·9
13·5
2·7
3·3
16·4
6·5
8·6
0·2
0·6
1·7
0·4
3·8
0·4
6·0
1·6
0·2
0·2
0·4
2·9
10·7
0·6
0·1
0·2
2·1
2·6
0·5
0·5
2·6
2·8
0·2
0·2
0·5
0·2
0·6
4·4
8·7
0·2
0·9
2·5
1·1
1·7
0·5
0·9
0·3
1·1
2·3
7·7
0·2
0·3
0·5
1·7
0·2
0·4
0·3
0·6
0·4
0·4
0·9
0·3
0·9
0·2
0·4
3·2
0·9
0·3
0·3
0·4
1·6
13·8
7·8
3·6
27·0
15·8
25·9
15·2
9·4
1·0
4·1
24·7
24·7
16·3
0·2
16·1
8·2
1·6
19·6
9·1
19·3
1·3
15·8
1·3
16·3
12·4
17·8
20·1
26·8
13·8
10·4
2·9
3·1
30·9
30·1
9·1
8·7
5·8
11·9
13·9
15·6
18·8
13·1
12·3
27·1
12·2
11·8
12·2
3·9
8·9
11·7
4·1
4·9
10·9
13·8
16·2
17·3
2·2
3·9
0·3
11·7
3·7
9·4
3·9
4·8
18·5
11·2
17·6
9·9
13·1
1·6
5·8
19·3
8·1
10·6
0·2
15·9
11·3
0·3
10·3
1·1
16·0
2·0
10·2
3·5
5·0
8·3
13·4
7·4
15·8
5·6
3·7
1·4
0·9
12·1
14·0
12·6
11·8
3·7
8·9
4·2
6·7
2·9
8·8
9·2
18·5
8·6
5·1
8·8
9·9
8·6
8·1
5·8
6·8
4·2
9·3
23·5
8·0
0·3
25·7
0·1
8·4
4·5
12·4
14·2
25·1
11·3
17·1
7·1
24·9
10·2
7·5
10·6
7·4
12·9
19·8
13·8
13·4
6·3
12·9
4·9
9·9
10·3
16·7
30·3
10·4
11·9
5·9
15·4
5·7
6·8
30·8
6·7
10·8
10·8
10·6
16·5
14·6
8·1
7·1
17·0
24·0
29·9
6·7
4·4
43·9
8·0
4·4
14·8
9·8
8·4
7·4
9·4
15·3
18·0
5·1
6·4
13·4
11·2
16·6
12·8
7·6
19·2
25·1
15·3
30·5
25·6
16·2
39·3
12·8
31·8
14·9
14·7
17·1
16·8
12·5
22·6
17·3
14·3
7·2
11·8
14·9
15·8
13·1
29·1
37·8
11·5
12·2
5·1
14·1
24·4
13·0
49·7
16·2
14·0
10·5
13·4
26·2
18·9
13·3
17·2
25·7
34·2
51·5
8·1
6·9
57·0
24·5
9·5
18·0
15·7
17·2
5·8
9·3
24·5
25·5
5·2
6·4
13·9
25·3
24·7
14·1
8·2
27·2
15·4
29·7
17·0
49·1
30·7
12·4
23·4
27·1
39·0
36·6
24·5
12·1
5·5
24·5
29·0
35·4
37·5
18·6
15·5
15·8
38·3
32·0
32·2
50·2
32·1
22·5
28·6
18·5
23·1
28·8
20·0
10·2
36·7
27·0
17·6
39·0
34·0
33·0
30·7
19·4
23·3
17·5
26·1
21·9
25·6
31·5
36·7
29·4
18·8
44·7
36·9
26·8
22·6
27·9
13·7
49·7
17·0
40·1
37·1
15·1
23·3
15·8
32·7
27·7
42·7
33·7
25·5
29·2
30·5
40·4
39·8
27·6
17·0
12·7
32·5
40·9
39·1
38·8
29·1
19·9
21·8
39·7
36·3
24·6
49·1
32·6
23·1
37·3
28·5
26·6
31·6
21·9
26·5
54·1
39·6
28·8
41·7
42·0
38·9
44·4
23·1
26·8
19·6
23·0
30·5
23·7
33·9
43·8
38·7
23·6
45·2
39·8
32·7
31·1
35·9
15·6
50·9
24·5
58·0
43·0
32·5
26·8
23·4
110·1
70·5
45·1
86·8
40·4
63·3
45·4
121·2
72·5
90·9
26·6
66·3
58·8
32·4
100·2
175·6
99·6
75·1
15·5
132·7
63·2
81·3
167·9
142·7
118·2
104·8
86·7
88·9
12·8
78·7
43·4
17·3
47·6
78·4
85·4
139·6
68·9
97·1
26·5
21·6
57·3
47·0
80·8
34·2
124·3
132·1
109·8
47·1
122·0
96·0
100·0
101·0
55·8
26·8
106·2
27·7
19·3
88·7
73·8
152·9
70·7
4·8
13·8
6·9
72·5
25·0
8·2
12·6
50·3
10·1
34·3
6·5
17·3
25·9
34·6
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17·6
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18·9
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26·8
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79·9
16·2
6·6
13·2
66·9
9·5
32·9
5·8
32·8
21·4
41·5
5·9
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21·5
23·9
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males in the multi-burden group (table 2). Uncertainty 
estimates for all cause DALYs,  YLL, and YLDs are 
reported in the appendix
In 2016, group 1 conditions accounted for 25% 
(63 million of 253 million DALYs) of the global DALY 
burden for adolescents (ﬁgure 2). 87% (55 million) of 
F M F M F M F M F M F M F M F M FF M F M F F
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Dominica
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Ecuador
El Salvador
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Greenland
Grenada
Guatemala
Honduras
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Iraq
Jamaica
Jordan
Kazakhstan
Libya
Mexico
Mongolia
North Korea
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Paraguay
Puerto Rico
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Saint Lucia
Saint Vincent and the Grenadines
Suriname
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Trinidad and Tobago
United Arab Emirates
Venezuela
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1·3
1·0
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1·5
1·5
1·3
1·7
1·8
1·5
1·1
0·9
1·2
1·4
1·0
1·4
1·8
0·9
1·0
1·4
0·9
1·4
1·5
0·9
1·2
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1·1
1·2
1·5
1·4
1·0
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1·4
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1·6
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1·7
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1·5
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2·0
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4·8
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3·9
5·9
5·8
5·3
36·0
4·3
5·8
4·4
4·8
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5·0
5·0
4·1
6·0
4·9
4·2
6·7
3·8
4·9
4·1
13·6
4·4
4·9
7·7
5·1
4·9
4·6
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5·4
4·0
4·5
6·7
8·6
6·0
1·0
1·2
1·4
1·2
1·2
1·2
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12·9
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1·0
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0·8
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1·7
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7·3
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9·5
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7·4
7·6
7·5
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9·8
7·4
7·7
8·4
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7·7
9·7
8·9
7·4
8·5
9·5
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8·1
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8·0
6·7
8·3
7·3
7·9
7·9
7·5
6·7
7·3
8·1
8·8
8·1
7·1
8·0
9·1
8·4
8·0
7·5
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7·4
7·9
7·5
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16·6
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8·7
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5·7
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9·9
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9·5
24·7
7·1
7·1
2·5
6·5
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22·6
9·7
10·2
18·7
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8·0
11·9
5·8
11·7
8·5
7·3
31·6
28·3
7·5
2·9
2·6
2·4
9·3
5·4
6·9
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0·4
3·9
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4·3
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2·9
1·5
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40·9
33·8
32·8
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49·9
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27·6
20·7
47·7
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40·5
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38·7
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35·7
34·3
30·3
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33·8
34·3
20·8
37·8
37·1
28·0
38·4
25·4
28·0
37·8
11·3
6·0
3·6
15·9
13·0
15·6
7·0
18·6
17·8
16·2
17·1
10·5
11·3
14·5
6·2
21·0
20·9
25·4
7·5
14·3
27·8
13·9
21·3
19·9
9·7
10·2
9·7
12·2
2·4
21·4
5·4
2·9
7·2
17·6
5·2
15·2
18·7
15·8
13·9
4·6
19·5
18·4
19·4
11·0
21·2
22·2
23·0
22·3
11·5
17·2
18·6
8·3
19·0
25·1
23·2
8·4
17·0
31·2
21·6
24·6
27·6
12·7
11·1
10·8
19·0
7·9
19·6
5·8
7·6
17·5
13·4
7·9
18·2
23·7
15·7
37·6
74·2
49·2
20·0
30·8
35·7
28·8
43·3
51·1
36·0
21·6
37·2
49·8
64·8
6·8
0·8
15·5
60·5
3·9
27·2
21·4
66·2
113·6
29·6
72·6
74·5
23·0
34·8
43·4
62·7
83·9
83·5
19·5
41·6
66·8
77·0
39·4
58·6
58·6
87·0
45·8
37·2
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49·0
61·9
74·8
50·9
39·6
93·6
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66·0
54·0
59·4
31·5
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47·6
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46·6
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37·2
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72·5
91·6
56·2
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94·0
54·1
70·6
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87·1
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69·6
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51·6
63·7
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9·7
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35·7
18·7
8·6
22·0
18·5
8·2
16·6
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14·8
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18·2
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0·6
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59·5
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14·5
23·5
16·6
22·4
30·5
47·6
66·9
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26·7
27·8
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28·5
32·7
10·6
22·5
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7·5
21·6
26·4
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26·1
7·0
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7·9
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35·9
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DALYs due to group 1 conditions were borne by 
adolescents in the multi-burden country group, with the 
prevalence of group 1 DALYs being 20% higher in females 
than in males in these countries (table 2; appendix). 
However, the global annual rate of change in group 1 
DALYs since 1990 was greater among females (–1·1%) 
than males (–0·9%), with a global decrease of 9·4 million 
DALYs due to group 1 conditions between 1990 and 2016 
(ﬁgure 2; appendix). Of multi-burden countries, Rwanda 
had the greatest annual decrease in group 1 DALYs from 
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1990 to 2016: –2·8% for females and –2·9% for males 
(appendix). In 2016, Lesotho and Central African Republic, 
both multi-burden countries, had the highest group 1 
DALY prevalence for females and males (>15 000 DALYs 
per 100 000 population), whereas Australia and France had 
prevalences of less than 500 DALYs per 100 000 population 
(ﬁgure 3). DALY prevalence due to group 1 conditions 
decreased in almost all countries, except in four multi-
burden countries (Lesotho, Swaziland, South Africa, 
Zimbabwe) and two injury-excess countries (Virgin 
Islands and Mozambique; appendix). Between 1990 and 
2016, females in Lesotho had the greatest annual increase 
in group 1 DALYs (6·8%) of any sex in any country. 
Uncertainty estimates for country-level estimates of group 
1 DALYs are shown in the appendix.
Injuries accounted for almost a ﬁfth (48 million [19%]) 
of the total DALYs for adolescents in 2016 (ﬁgure 2). In 
2016, 53% (25 million) of DALYs due to injury were borne 
by adolescents in multi-burden countries, and 11 million 
(23%) were in injury-excess settings (despite comprising 
only 13% of the global population of adolescents; 
appendix). Globally, DALY prevalence due to injuries was 
almost three times higher among males than females 
(table 2). This sex diﬀerence was more substantial in 
injury-excess countries than in the other country groups, 
with the prevalence of DALYs for males four-times higher 
than for females (table 2). As a result, males carried 
almost 75% of all DALYs due to injury (35·5 million of 
48 million DALYs) in 2016, with almost 40% of the global 
injury burden being among males in multi-burden 
Figure 3: Multi-burden (A), injury-excess (B), and non-communicable disease-predominant (C) country-specific estimates of the 12 indicators for adolescent health and wellbeing, by sex
Data are most recent country-level estimates for each indicator (2010 for education [except New Zealand, 2005], median of 2013 for child marriage, median of 2015 for NEET, and 2016 for all others), 
blank spaces indicate missing data. Health outcomes are DALYs per 100 adolescents, and health risks and social determinants are prevalences, unless otherwise stated. Data are for adolescents aged 
10–24 years, unless otherwise stated. For each indicator and sex, countries are shaded on a scale from green (best value observed) to red (worst value observed); for most indicators green signifies the 
lowest value with the exception of secondary education and demand for contraception satisfied for which it signifies the highest value. DALYs=disability-adjusted life-years. F=females. M=males. 
NEET=not in education, employment, or training. *For individuals aged 15–19 years. †For individual aged 20–24 years. ‡For individuals aged 15–24 years.
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settings (18 million DALYs; appendix). Although the 
global DALY count decreased by 7·8 million DALYs 
due to injury between 1990 and 2016 (ﬁgure 2), males 
had a smaller rate of annual change than females 
did, particularly in injury-excess countries (table 2). In 
2016, the highest prevalence of DALYs due to injury 
(>10 000 per 100 000 adolescents) for males were in 
the injury excess countries Syria, Iraq, and Venezuela, 
and the multi-burden countries Afghanistan, Yemen, and 
Lesotho (ﬁgure 3). In 2016, the prevalence of injury 
DALYs for females were highest (>5000 per 100 000) in 
Syria, Afghanistan, Yemen, and Iraq. Syria had an average 
annual increase in the prevalence of injury DALYs of 
42·8% for females and 38·0% for males between 1990 
and 2016 (appendix).
In 2016, non-communicable diseases were the leading 
contributor to disease burden in adolescents, accounting 
for 56% (142 million) of 253 million of global adolescent 
DALYs. 55% (78·8 million DALYs) of the global non-
communicable disease burden was borne by adolescents 
in multi-burden countries, and 31% (44·2 million DALYs) 
by adolescents in non-communicable disease-pre dom-
inant countries (appendix). In 2016, the prevalences of 
DALYs due to non-communicable diseases were higher 
in multi-burden and injury-excess countries than in non-
communicable disease-predominant countries (table 2). 
Rates of change in DALYs were substantially lower for 
DALYs due to non-communicable disease than for DALYs 
due to injuries or group 1 conditions (table 2). An overall 
increase of 6·1 million DALYs due to non-communicable 
diseases between 1990 and 2016 was driven largely by 
population growth (appendix). Greenland, an injury-excess 
country, and several multi-burden countries in the Paciﬁc 
(eg, Kiribati, Solomon Islands, Vanuatu, and Papua New 
Guinea) had the highest prevalences of DALYs from non-
communicable diseases (ﬁgure 3). We could not calculate 
uncertainty estimates for the modiﬁed groups and so we 
provide country-level uncertainty estimates for IHME 
level 1 groups of injury, non-communicable disease, and 
separately for self harm in the appendix.
Health risks
In 2016, 136 million adolescents smoked daily (112 million 
males and 25 million females), a decrease of 38 million 
compared with 1990 (ﬁgure 2). Of smokers in 2016, 
67 million (49%) lived in non-communicable disease-
predominant countries and 52 million (38%) in multi-
burden countries (appendix). Daily smoking prevalence 
was higher among males across all country groups, and 
was highest in the injury-excess (13·8 million [11%] of 
122 million males and 3·3 million [3%] of 117 million 
females; table 2) and non-communicable disease-
predominant group (52·4 million [17%] of 312 million 
males, 14·7 million [5%] of 287·6 million females; 
table 2). The prevalence of tobacco use decreased from 
1990 to 2016, except among females in multi-burden 
countries where, although levels remain low, a small 
annual increase has occurred since 1990 (1·2%; table 2). 
Furthermore, in 2016, 40% (45·4 million of 111·5 million) 
of male daily smokers and 27% (6·8 million of 
24·8 million) of female daily smokers were in multi-
burden countries, which is a substantial increase 
compared with 1990 (41·1 million [30%] of 139·8 million 
male smokers and 4·1 million [12%] of 34·4 million 
female smokers. In 2016, smoking prevalence was over 
20% for females in the injury-excess country Greenland, 
and in the non-communicable disease-predominant 
countries Bulgaria, Chile, and Croatia (ﬁgure 3). For 
males, the smoking prevalence was over 25% in the 
multi-burden countries Indonesia and Papua New 
Guinea, the injury-excess countries Greenland and 
Georgia, and the non-communicable disease-predom-
inant countries Ukraine, Latvia, Bulgaria, Mauritius, 
Armenia, and Cyprus (ﬁgure 3). Smoking increased 
more than 5% annually from 1990 to 2016 for females 
living in Egypt, Montenegro, South Korea, Kyrgyzstan, 
India, and Palestine, and for males living in Montenegro 
(appendix).
In China in 2016, 20% (26·8 million of 134·4 million) of 
males were smoking daily compared with 1% (1·4 million 
of 118·3 million) of females, with an annual change of 
–0·8% for males and –1·9% these prevalences are 
decreasing (appendix). Conversely, smoking prevalence is 
increasing in India (6·4% annual increase for females and 
0·4% annual increase for males), although the prevalence 
in 2016 was relatively low, with 3% (4·3 million of 
175·1 million) of females and 8% (14·8 million of 
195·0 million) of males smoking daily (appendix). 
In 2016, 71 million adolescents aged 15–19 years reported 
binge drinking in the past 12 months (44 million males 
and 27 million females), a small increase since 1990 
(41 million males and 26 million females; ﬁgure 2). 
39 million (55%) adolescents who reported binge drink-
ing lived in non-communicable disease-predominant 
countries, 19 million (26%) lived in multi-burden settings, 
and 13 million (19%) lived in injury-excess countries 
(appendix). However, the prevalence of binge drinking 
was highest in countries that were non-communicable 
disease predominant (23·7 million [24%] of 98·7 million 
males and 15·5 million [17%] of 91·1 million females aged 
15–19 years) and injury excess (8·1 million [20%] of 
40·0 million males and 5·2 million [14%] of 38·3 million 
females aged 15–19 years). The prevalence of binge 
drinking changed little over time and females in multi-
burden countries had the most substantial annual 
increase from 1990 to 2016 (0·7%). Substantial diﬀer-
ences were observed between countries (ﬁgure 3). The 
pre valences of binge drinking among females aged 
15–19 years living in Ireland, Denmark, New Zealand, and 
Finland—all non-communicable disease-predominant 
countries—were greater than 55% (ﬁgure 3). For males, 
the prevalence of binge drinking was over 60% in Austria, 
Denmark, and Finland—also all non-communicable 
disease-predominant countries (ﬁgure 3). By contrast, the 
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multi-burden countries Bangladesh and Pakistan and the 
non-communicable disease pre dominant country Egypt 
had prevalences under 1% (ﬁgure 3). Ethiopia showed the 
greatest overall annual increase between 1990 and 2016 
(2·3% for females and 3·6% for males), whereas Zambia 
had the greatest decrease (–2·0% for females and 
–2·2% for males), both of which are multi-burden 
countries (appendix). In China in 1990, the prevalence of 
binge drinking was 5% in females (2·8 million of 
60·1 million) and 15% in males (9·4 million of 63·6 million), 
which had increased by 2016 to 8% for females (2·7 million 
of 35·8 million) and 18·2% (7·4 million of 40·8 million). In 
India in 2016, prevalence of binge drinking was low, at 1% 
(0·5 million of 58·7 million) for females and 3% 
(2·0 million of 65·4 million) for males. The prevalence of 
binge drinking in India appears relatively steady over 
time, with the rate of change from 1990 to 2016 varing by 
less than a percent for  females (–0·5%) and males (0·4%).
In 2016, almost one in ﬁve (324 million [18%]) of the 
world’s adolescents was overweight or obese; a 120% 
(176·8 million) increase from the 147·3 million adol-
escents who were overweight or obese in 1990 (ﬁgure 2). 
This increase in overweight and obese adolescents was 
driven by changes in the prevalence of overweight and 
obesity rather than population change (appendix). In 
2016, 144 million (44%) overweight or obese adolescents 
lived in non-communicable disease predominant 
countries and 116 million (36%) in multi-burden 
countries. In 2016, the prevalence of overweight and 
obesity was highest for adolescents in the non-com-
municable disease-predominant (144·1 million [24%] of 
600 million) and injury-excess countries (64 million [27%] 
of 239 million), with higher prevalences among males 
than females in non-communicable disease-predominant 
countries, and higher prevalences among females than 
males in the injury-excess and multi-burden countries 
(table 2). Since 1990, a substantial increase in overweight 
and obesity occurred annually for both males and females 
in all country groups, but this increase was particularly 
prominent for females in multi-burden countries (5·7%; 
table 2). Females living in the non-communicable disease-
predominant countries American Samoa and Samoa and 
the multi-burden countries Equatorial Guinea and Tonga 
had the highest prevalences of overweight and obesity, all 
more than 55% (ﬁgure 3). For males, prevalence was 
greater than 50% in the non-communicable disease-
predominant countries American Samoa, Kuwait, and 
Qatar (ﬁgure 3). Only one country (Democratic Republic 
of the Congo) had a decrease in overweight and obesity 
over time (appendix). Both China and India had large 
increases in the prevalence of overweight and obesity, 
with males in both countries having an annual rate of 
change of 6·2%, whereas females had annual rates of 
change of 4·8% in China and 8·5% in India (appendix)
Anaemia aﬀected almost one in four adolescents 
globally (430 million [24%]) in 2016, an increase of 20% 
from 357 million in 1990. This increase in the number of 
adolescents with anaemia was largely driven by changing 
demography (appendix). In 2016, 333 million (77%) 
adolescents with anaemia lived in multi-burden settings, 
an increase of 75 million compared with 1990 (appendix). 
45% (194 million) of adolescents with anaemia lived in 
India and China. The prevalence of anaemia was higher 
for females than for males across all groups, and was 
highest for both males and females in multi-burden 
countries, with 40% (188 million of 467 million) of 
females in multi-burden countries having anaemia 
(table 2). Prevalence of anaemia decreased over time for 
all country groups for both males and females but the rate 
of change was small, with an annual decrease of only 0·4% 
for both sexes in multi-burden countries. Prevalence of 
anaemia was more than 50% for females in the multi-
burden countries Bhutan, Yemen, India, and Burkina 
Faso. For males, prevalence was highest (>45%) in the 
multi-burden countries Yemen, Mali, Burkina Faso, and 
Sudan. The lowest prevalences of anaemia (<4%) averaged 
between the sexes were in non-communicable disease-
predominant countries—speciﬁcally, Sweden, France, 
Australia, Denmark, Belgium, and Ireland (<4%; ﬁgure 3).
Social determinants of health
Globally in 2010, an estimated 325 million adolescents 
aged 20–24 years (just over half the total population of 
620 million adolescents aged 20–24 years [303 million 
males and 317 million females]) had completed secondary 
education, an increase of 136 million since 1990. However, 
with little change from the estimated 300 million not 
completing education in 1990, an estimated 295 million 
(61%) adolescents aged 20–24 years had not completed 
secondary education in 2010 (159 million in multi-burden 
countries, 36 million in injury-excess countries, and 
100 million in non-communicable disease-predominant 
countries). The proportion of adolescents who completed 
secondary education was lowest in multi-burden 
countries, with only 42% (49·2 million of 116·8 million) 
of females and 43% (52·4 million of 121·8 million) of 
males aged 20–24 years, estimated from 47 multi-burden 
coutries with data, completing secondary education in the 
multi-burden group in 2010 (table 2). However, the 
greatest increases in completion of secondary education 
have been in multi-burden countries, with a 14·9% annual 
increase for females aged 20–24 years since 1990. Females 
living in the non-communicable disease-predominant 
countries Taiwan, South Korea, the USA, and Croatia, 
and the multi-burden country Fiji had secondary school 
completion greater than 95% (ﬁgure 3). For males, 
prevalence of secondary school completion was highest 
(>95%) in the non-communicable disease-predominant 
countries South Korea, the USA, Taiwan, and Singapore 
(ﬁgure 3). Several multi-burden countries had prevalences 
of completion of less than 5%: Congo and The Gambia 
for females, and Zimbabwe and Tanzania for males 
(ﬁgure 3). Large diﬀerences in secondary school com-
pletion by sex were seen in some countries. Females 
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living in Barbados, Qatar, and Libya were twice as likely to 
complete secondary education as males were. By contrast, 
males living in Congo, Afghanistan, The Gambia, Haiti, 
Central African Republic, and Democratic Republic of 
Congo were twice as likely to complete secondary 
education as females were (ﬁgure 3). Females living in 
the multi-burden countries Yemen, India, Malawi, and 
Mali and the injury-excess country Vietnam had more 
than 30% annual increases in secondary school 
completion between 1990 and 2010 (appendix).
Most recent estimates indicate 238 million adolescents 
aged 15–24 years were NEET (175 million females and 
63 million males), of whom 60% (142 million adolescents, 
117 million females and 25 million males) lived in multi-
burden settings. Global prevalence of NEET was around 
three times higher among females (33% [138 million of 
421 million]) than among males (10% [44·4 million 
of 443·0 million]) aged 15–24 years, estimated from 
123 countries with available NEET data, with the sex 
diﬀerence being particularly noticeable for multi-burden 
countries (table 2; appendix). Females living in the 
multi-burden countries Yemen, India, and Pakistan, and 
the injury-excess countries Honduras, and Trinidad and 
Tobago had NEET prevalences of more than 50% 
(ﬁgure 3). Males living in the injury-excess countries 
Trinidad and Tobago and Panama and the non-
communicable disease-predominant countries Samoa 
and Armenia had prevalences of NEET of more than 
35% (ﬁgure 3). Large sex diﬀerences in NEET were seen 
in India, with the prevalence of NEET among female 
adolescents being more than 15 times higher than 
among males, and in Pakistan, being more than seven 
times higher than among males (ﬁgure 3). Insuﬃcient 
data were available to calculate the rate of change in 
NEET prevalence for all countries (appendix).
In 2016, adolescent mothers aged 15–19 years had 
11·7 million livebirths (this number is for new births, and 
does not include girls aged 15–19 years who gave birth 
before 2016), a 25% decrease from 15·7 million in 1990. In 
2016, 73% (8·5 million) of adolescent livebirths occurred 
in multi-burden countries, 17% (2 million) in injury-
excess countries, and 11% (1·3 million) in non-com-
municable disease-predominant countries (appendix). 
The rate of livebirths among adolescents was highest 
in multi-burden and injury-excess countries compared 
with non-communicable disease-predominant countries 
(table 2). The rate of livebirths among adolescents 
decreased substantially across all country settings, but the 
smallest decrease was in the injury-excess group (table 2). 
Of the 30 countries with the highest adolescent live-
birth rate, 28 (93%) were classiﬁed as multi-burden 
(ﬁgure 3). Niger had the highest rate of adolescent births 
(175 livebirths per 1000 females aged 15–19 years per year), 
with Mali, Angola, Malawi, Guinea, Mozambique, and 
Côte d’Ivoire all having rates between 167 and 132 live-
births per 1000 females aged 15–19 years per year. Of the 
50 countries with the lowest rates of adolescent births, 
46 (92%) were non-communicable disease-predominant 
countries (ﬁgure 3). South Korea, North Korea, and 
Switzerland had rates of adolescent births below three per 
1000 females aged 15–19 years per year. Ten countries 
had an increase in the rate of adolescent livebirths 
between 1990 and 2016: the non-communicable disease-
pre dominant countries Azerbaijan, Malta, and Albania; 
the injury-excess countries Iraq and Vietnam; and 
the multi-burden countries the Philippines, Zimbabwe, 
Lesotho, Cambodia, and Democratic Republic of the 
Congo (appendix).
For child marriage, data were only available for 
31 (35%) of 88 countries in the non-communicable 
disease-predominant group, which covered 18% of 
females aged 20–24 years in this group. Using data from 
2003–16 (the most recent year of data collection varied 
between countries, median year of data collection was 
2013), we estimated that 66 million females aged 
20–24 years reported being married before the age of 18, 
of whom an estimated 51·5 million (79%) lived in multi-
burden countries, 10·1 million (15%) lived in injury-
excess countries, and 4·0 million (6%) lived in 
non-communicable disease-predominant countries. 
Preva lence of child marriage was high in multi-burden 
countries, with 38% (50·5 million of 132·3 million 
females estimated from 66 countries with available 
data) of females aged 20–24 years in the multi-burden 
group married before age 18 years. Niger, Chad, Central 
African Republic, Mali, Bangladesh, Guinea, Burkina 
Faso, and South Sudan—all multi-burden countries—
had prevalences of child marriage of more than 50% 
(ﬁgure 3). Child marriage was also high (>20%) in 
some non-communicable disease-predominant countries 
situated predominantly in central America and Latin 
America, including Cuba, Uruguay, Bolivia, Peru, and 
Costa Rica (ﬁgure 3). Rate of change could not be 
calculated because of the lack of data.
In 2016, of 219·1 million females aged 15–24 years, 
146·0 million (67%) had their demand for contraception 
satisﬁed with modern methods (49·5 million [34%] in 
multi-burden countries, 23·5 million [16%] in injury-
excess countries, and 73 million [50%] in non-com-
municable disease-predominant countries), an increase 
of 61 million since 1990 (ﬁgure 2; appendix). Despite 
this increase, unmet demand also increased from 
68·4 million (45%) in 1990 to 73·1 million (33%) in 2016. 
The prevalence of females who had their contraceptive 
needs met was higher in non-communicable disease-
predominant countries than in injury-excess and multi-
burden countries (table 2). Rates of annual improvement 
since 1990 were greatest in multi-burden countries 
(2·1%; table 2). Countries that notably had a low 
prevalence of demand for contraception being satisﬁed 
(ie, <20%) were the multi-burden countries South Sudan, 
Somalia, Chad, Mauritania, and Eritrea, and the non-
communicable disease-predominant country Macedonia 
(ﬁgure 3). Countries with the highest prev alence of 
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demand satis ﬁed (>85%) were mostly in the non-
communicable disease-predominant group, inc luding 
Australia, the Netherlands, Cuba, Taiwan, New Zealand, 
the UK, France, and Finland, but also the injury-excess 
countries Thailand and Paraguay, and the multi-burden 
country South Africa (ﬁgure 3). Among all countries, 
the multi-burden countries Burundi, Senegal, and 
Guinea-Bissau had the most substantial improvements in 
demand satisﬁed, each with a more than 25% increase 
annually (appendix). Prevalence of demand satisﬁed 
decreased in ten countries over time; Serbia, a non-com-
municable disease-pre dominant country, and Guyana, 
multi-burden country, had annual decreases in prevalence 
of more than 1% (appendix).
Discussion
Great changes have occurred in adolescent health over 
the past 25 years. The decrease in disease burden due to 
group 1 conditions and injuries has been particularly 
notable, with most countries now predominant in non-
communicable diseases. However, the epidemiological 
transition has coincided with rapid demo graphic 
changes. Today’s non-communicable disease-predom-
inant and injury-excess countries have fewer adolescents 
than they did in 1990; by contrast, the number of 
adolescents in multi-burden countries has greatly 
increased. As a result, 35% more adolescents were living 
in multi-burden countries in 2016 than in 1990. Shifts in 
health risks since 1990 were equally sobering. Nutritional 
risks have become more prominent than in 1990, with 
the number of overweight or obese adolescents more 
than doubling and the number of adolescents with 
anaemia increasing by 20% during this period. Despite 
having been a focus of policy attention in many high-
income countries, the number of adolescents who binge 
drink has not shifted since 1990, and although the global 
number of adolescent daily smokers has decreased by 
around 20%, the global prevalence among males aged 
10–24 years is still over 10%.
One area of clear progress has been in secondary school 
completion, particularly for girls. Even so, only around 
half of the world’s adolescents are completing secondary 
education and the absolute number of adolescents not 
completing secondary education in 2010 is little changed 
from 20 years earlier. Progress was seen  in livebirths to 
adolescent mothers, an important determinant of health 
for girls and young women, but the rate of livebirths 
remains high in many multi-burden and injury-excess 
countries. Continued high prevalences of child marriage 
and substantial inequalities in NEET between the sexes 
suggest that inequitable gender norms remain powerful 
determinants of adolescent health and wellbeing.
Satisfaction of demand for contraception for females 
was included as an indicator of the extent to which health 
systems can deliver an essential resource for health 
that is sensitive to social norms. We observed improve-
ments for this indicator across each country grouping, 
particularly for multi-burden countries, but with great 
variation between countries in the prevalence of demand 
satisﬁed. However, in 2016, 73 million young women did 
not have their demand for contraception met with modern 
methods, an increase of 5 million since 1990, suggesting 
that improvements in access to contraception have not 
kept pace with need.
These changes in adolescent health outcomes, health 
risks, and social determinants must be interpreted in 
light of demographic changes. Although the prevalences 
of tobacco smoking are still lower in most multi-burden 
countries than in most non-communicable disease-
predominant countries, 41% of male and 27% of female 
daily smokers now live in multi-burden countries, a 
substantial increase compared with 1990 (29% of male 
and 12% of female daily smokers). High prevalences 
of tobacco use (>25%) for males in multi-burden (eg, 
Indonesia and Papua New Guinea) and injury-excess 
countries (eg, Georgia and Greenland) highlight where 
tobacco control eﬀorts are urgently needed. This need is 
also true for countries where the prevalence of smoking is 
increasing rapidly, such as for females in Palestine and 
India. Equally, although the prevalence of anaemia has 
decreased in multi-burden countries, this decrease has 
been out-paced by population growth so that, compared 
with 1990, an additional 74 million adolescents with 
anaemia were living in multi-burden countries in 2016. 
This increase in unmet adolescent health needs has 
emerged despite growing availability of evidence-based 
interventions.1 Unmet need around adolescent non-
communicable diseases and associated health risks 
remains a priority in countries that have passed through 
the epidemiological transition. However, the greatest 
challenges in adolescent health are in low-resource multi-
burden countries where adolescents commonly face a 
triple disease burden from group 1 conditions, injuries, 
and non-communicable diseases, and health systems 
have largely not kept pace with demographic change.
Therefore, multi-burden countries are a priority for 
advancing global adolescent health. To achieve the 
target of no country being in the multi-burden disease 
group by 2030,1 group 1 conditions would need 
to decrease by almost 4000 DALYs per 100 000 adolescents 
in the next 15 years, an annual decrease of approxi-
mately 4%. This annual change is about three times 
more than that observed in the multi-burden group for 
1990–2016; only Rwanda in this group achieved an 
annual decrease of almost 3%. Tackling adolescent 
health in multi-burden countries will need to accelerate 
progress around structural and social determinants of 
health, including access to quality education and health 
services, provision of opportunities for employment, 
and achieving equitable gender norms.1 Our analysis 
high lights the need to address non-communicable 
diseases for all adolescents, and since mental disorders 
are a major contributor to non-communicable disease 
burden, a speciﬁc focus on mental disorders will be 
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needed,22 and chronic and relapsing physical health 
problems that aﬀect adolescents in all settings.1 
Overweight and obesity emerged as pervasive health 
risks, with the highest prevalence in non-communicable 
disease-predominant countries, but with rates of change 
increasing rapidly globally. Given that recovery from 
adolescent overweight and obesity is rare once established, 
the consequences on health in later life and for the next 
generation will be great.2 Given the health implications, 
the omission of adolescent overweight and obesity from 
the SDGs is a major policy gap.
Some improvements probably reﬂect action under the 
Millennium Development Goals, including a lower sex 
disparity in educational attainment than in 1990 and 
decreases in the rate of adolescent births.23 Despite 
progress in education, 117 million young women in multi-
burden countries are NEET, comprising almost half of all 
adolescents who are NEET. Although essential, promotion 
of education alone will be insuﬃcient to achieve equity 
between the sexes in the social determinants of health 
and wellbeing during adolescence. In part, this high 
prevalence of NEET among young women in multi-
burden countries could be explained by continuing high 
rates of adolescent livebirths, which disrupts education 
and in turn restricts prospects for employment.24 In many 
multi-burden countries, prevalences of child marriage 
also continue to be high, reﬂecting harmful gender 
norms. Achieving gender equity in determinants of 
adolescent health and wellbeing will require action on 
many fronts, including employment and economic 
empowerment, better access to essential health care 
including contraception, implementation of legislative 
frameworks to protect girls from early marriage, and 
changes in community norms.
Beyond education, HIV, and sexual and reproductive 
health, adol escents have been largely absent in global 
health investments.25 Perhaps reﬂecting this neglect, the 
overall annual decrease in global disease burden for 
adolescents of 0·8% for females and 0·6% for males was 
less than the decrease of 1·2% annual change in the age-
standardised rate of total DALYs found by GBD 2016 
between 1990 and 2016.18 Here we found 53% of adolescents 
in multi-burden countries had their demand for modern 
contraception satisﬁed in 2016, and Niamh Cahill and 
colleagues’ found a prevalence of less than 68% among 
married women living in 69 of the world’s poorest 
countries in 2017.26 These ﬁndings are likely to reﬂect lower 
health-care access among adolescents than among adults, 
and unmet needs are likely to be even greater for other 
health needs such as mental disorders.8
China and India are home to a third of the world’s 
adolescents and present contrasting examples of 
adolescent health. China has progressed rapidly from an 
injury-excess country to a non-communicable disease-
predominant country at a time when its adolescent 
population has decreased by 28%. Although improve-
ments in adolescent health outcomes in China have 
been impressive, the prevalence of smoking and binge 
drinking is high (higher  for males than for females), and 
prevalences of overweight and obesity are increasing. By 
contrast, India has remained a multi-burden country and 
the number of adolescents has increased by 40%. Health 
risks in India, although relatively low by global standards, 
are increasing rapidly, but perhaps more pressing is 
the large disease burden and gender inequality across 
the social determinants. The USA stands out for its 
poor adolescent health compared with other high-income 
or non-communicable disease-predominant countries. 
Although not as high as in injury-excess countries, 
injury-related DALYs in the USA were higher than in 
similar high-income countries. 17·4% of females and 
15·6% of males aged 15–24 years in the USA were NEET 
in 2016. The USA’s comparatively low prevalence of 
demand for modern contraception satisﬁed (70·9%) 
also raises questions about the responsiveness of the 
health system, while the high prevalence of overweight 
and obesity (44·3% for females and 44·9% for males) 
suggests a lack of public health responses.
The Commission’s headline indicators were designed 
to capture shifts in adolescent health with progress 
through the epidemiological transition.1 Since mortality 
alone is a poor indicator of health for adolescents 
compared with other age groups, we used DALYs as a 
summary measure of health need. DALYs rely on good 
primary data to estimate their YLL and YLD components, 
which even for mortality are often lacking for the 
adolescent age groups.22,27 Grouping countries by disease 
burden appears to be useful for policy and programming 
because both health risks and social determinants of 
health tended to cluster by these country groups. This 
observation suggests that this grouping by disease 
burden might be useful in indicating a package of actions 
relevant to countries within a group. In particular, injury-
excess countries are a group that cannot be readily 
identiﬁed by their level of socioeconomic development or 
income grouping.28
To populate indicators of health risks and determinants, 
some modiﬁcations of the deﬁnitions were needed. 
The most notable change was for the indicator of 
iron deﬁciency anaemia as an indicator of poor 
nutritional status, which we modiﬁed to anaemia. 
Because most cases of anaemia globally have a primary 
nutritional origin, anaemia remains useful as an 
indicator of undernutrition and is particularly relevant 
for adolescents in the context of rapid growth and 
menstruation.29 We deﬁned the indicator of smoking to 
speciﬁcally refer to tobacco smoking to measure smoked 
products and we did not include emerging behaviours 
such as vaping. Our measure of binge drinking adopted 
a commonly used timeframe of 12 months, but a shorter 
timeframe might have been more useful in deﬁning a 
clearer risk group. Educational attainment data from 
Barro-Lee, which had good coverage, was only available 
up to 2010. We were also unable to stratify these 
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indicators by urban or rural status and socioeconomic 
wealth as originally proposed. Tracking policy and 
practice at country and local level will undoubtedly 
require additional indicators and stratiﬁ cation to capture 
inequalities across disadvantaged groups including 
ethnic minorities, Indigenous populations, LGBT+ 
(lesbian, gay, bisexual, transgender, and other identities), 
young oﬀenders, and migrants or displaced young 
people.
Serial estimates of child marriage were not available 
for many countries and were largely unavailable for 
non-communicable disease-predominant high-income 
countries. To present a global estimate, we assumed that 
in non-communicable disease-predominant countries 
without data the prevalence of child marriage would be 
similar to the lowest observed estimates within that 
disease group (1·6%). This assumption is likely to have 
resulted in an underestimation of total numbers—eg, in 
the USA, a country without recent comparable data, in 
2002 an estimated 6% of females and 2% of males were 
married by the age of 18 years.30
To maximise data coverage, ten of 12 indicators were 
populated using modelled data, which enabled better 
data coverage and is an advance on earlier eﬀorts in 
which, even with optimal indicator deﬁnitions, only 
seven of 25 indicators covered at least 50% of the 
world’s adolescents.7 Modelled data provide more 
complete estimates, including trends over time, but 
wide uncertainty estimates show the poor quality and 
availabilty of underlying primary data for some 
measures. The uncertainty estimates for DALYs due to 
non-communicable diseases were both wide and 
similar across countries, suggesting poor primary data 
and a heavy reliance on modelling. For countries in 
conﬂict and war (eg, Syria and Iraq in 2016), large 
uncertainty estimates for injury also indicate a paucity 
of primary data. For estimates of binge drinking for all 
countries, large uncertainty estimates also indicate the 
paucity of primary data.7
A burgeoning adolescent population in many low-
income and middle-income countries could provide an 
unprecedented demographic dividend through the 
entry into the workforce of an educated and healthy 
cohort with fewer dependants than previous generations. 
A triple burden of adolescent disease, together with 
continued high prevalences of early marriage and 
adolescent livebirths in many resource-limited settings, 
will diminish the likelihood of a demographic dividend. 
Health risks associated with nutrition and substance 
use aﬀect adolescent growth and development and 
ultimately health trajectories in later life. Not addressing 
social and structural determinants of health, including a 
lack of quality education, few employ ment opportunities, 
continuing high prevalences of early pregnancy, and 
inequitable gender norms diminish this generation’s 
prospects for health, wellbeing, and economic partici-
pation. Health, education, and legal systems have not 
kept pace with demographic shifts and growing geo-
graphical inequality in adolescent health needs. Despite 
improvements in many settings, the adolescent health 
challenge is greater today than it was 25 years ago. The 
case for comprehensive and integrated invest ments in 
adolescent health, growth, and development has never 
been stronger.
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